Jpmorgan Chase & CO Vor Biopharma Inc. Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 12,038 shares of VOR stock, worth $16,853. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,038
Previous 983 1124.62%
Holding current value
$16,853
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 26, 2024
BUY
$0.7 - $1.1 $7,738 - $12,160
11,055 Added 1124.62%
12,038 $8,000
Q3 2024

Nov 08, 2024
BUY
$0.7 - $1.1 $7,738 - $12,160
11,055 Added 1124.62%
12,038 $8,000
Q2 2024

Dec 26, 2024
SELL
$1.0 - $2.2 $11,055 - $24,321
-11,055 Reduced 91.83%
983 $0
Q2 2024

Aug 12, 2024
SELL
$1.0 - $2.2 $15,204 - $33,448
-15,204 Reduced 93.93%
983 $0
Q1 2024

Dec 26, 2024
BUY
$1.8 - $2.85 $7,468 - $11,824
4,149 Added 34.47%
16,187 $38,000
Q1 2024

May 10, 2024
SELL
$1.8 - $2.85 $14,959 - $23,686
-8,311 Reduced 33.93%
16,187 $38,000
Q4 2023

Dec 26, 2024
BUY
$1.66 - $2.63 $20,683 - $32,769
12,460 Added 103.51%
24,498 $55,000
Q4 2023

Feb 12, 2024
SELL
$1.66 - $2.63 $1,342 - $2,127
-809 Reduced 3.2%
24,498 $55,000
Q3 2023

Nov 14, 2023
SELL
$2.1 - $3.35 $11,766 - $18,770
-5,603 Reduced 18.13%
25,307 $53,000
Q2 2023

Aug 11, 2023
SELL
$3.09 - $5.33 $299,819 - $517,164
-97,029 Reduced 75.84%
30,910 $95,000
Q4 2022

Feb 13, 2023
SELL
$3.77 - $7.43 $4,301 - $8,477
-1,141 Reduced 0.88%
127,939 $851,000
Q3 2022

Nov 14, 2022
SELL
$3.9 - $5.52 $164,958 - $233,479
-42,297 Reduced 24.68%
129,080 $514,000
Q2 2022

Aug 11, 2022
SELL
$3.89 - $6.44 $45,929 - $76,037
-11,807 Reduced 6.45%
171,377 $852,000
Q1 2022

May 11, 2022
SELL
$6.04 - $12.23 $125,505 - $254,127
-20,779 Reduced 10.19%
183,184 $1.11 Million
Q4 2021

Feb 10, 2022
SELL
$11.32 - $18.02 $270,106 - $429,975
-23,861 Reduced 10.47%
203,963 $2.37 Million
Q3 2021

Nov 12, 2021
BUY
$12.24 - $20.38 $2.79 Million - $4.64 Million
227,824 New
227,824 $3.57 Million

Others Institutions Holding VOR

# of Institutions
55
Shares Held
41.1M
Call Options Held
9.3K
Put Options Held
100
View Full List

About Vor Biopharma Inc.

VOR Quotes by TradingView
  • Ticker VOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,056,300
  • Market Cap $53.3M
  • Description
  • Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...
More about VOR
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email